Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Kern

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Kardiologia Polska|January 24, 2012
First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months resultsRobert J Gil, Dobrin Vassiliev, Aleksandra Michałek, et al.
Kardiologia Polska|September 29, 2020
Association of serum sclerostin levels with atherosclerosis severity in patients referred for invasive coronary angiographyAdam Kern, Tomasz Stompór, Jolanta Kiewisz, et al.
Journal of Personalized Medicine|April 3, 2021
The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-UpAdam Kern, Tomasz Stompór, Jolanta Kiewisz, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 15, 2015
Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registryRobert J Gil, Jacek Bil, Maik J Grundeken, et al.
Journal of Pediatric Surgery|June 4, 2014
Initial bladder closure of the cloacal exstrophy complex: outcome related risk factors and keys to successBhavik B Shah, Heather Di Carlo, Seth D Goldstein, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 25, 2015
Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trialRobert J Gil, Jacek Bil, Maik J Grundeken, et al.
Journal of Clinical Medicine|June 27, 2024
Ten-Year Outcomes in Patients Undergoing Simultaneous Coronary and Renal Angiography-Does Renal Artery Stenosis Matter?Adam Kern, Tomasz Stompór, Krystian Bojko, et al.
Kardiologia Polska|March 20, 2025
Ten-year outcomes of patients undergoing simultaneous coronary and renal angiography: Insights from the KORONEF Registry based on chronic kidney disease and eGFR stratificationAdam Kern, Tomasz Stompór, Krystian Bojko, et al.
Journal of Clinical Medicine|October 26, 2024
Soluble Urokinase Plasminogen Activator Receptor as a Predictor of All-Cause Death in Patients Undergoing Coronary Angiography at 10-Year Follow-UpAdam Kern, Tomasz Stompór, Krystian Bojko, et al.
Biomedicines|January 8, 2025
Comparative Ten-Year Outcomes in Chronic and Acute Coronary Syndrome Patients Undergoing Invasive Diagnostics-Insights from the KORONEF RegistryAdam Kern, Tomasz Stompór, Krystian Bojko, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Kardiologia Polska|January 24, 2012
First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months resultsRobert J Gil, Dobrin Vassiliev, Aleksandra Michałek, et al.
Kardiologia Polska|September 29, 2020
Association of serum sclerostin levels with atherosclerosis severity in patients referred for invasive coronary angiographyAdam Kern, Tomasz Stompór, Jolanta Kiewisz, et al.
Journal of Personalized Medicine|April 3, 2021
The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-UpAdam Kern, Tomasz Stompór, Jolanta Kiewisz, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 15, 2015
Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registryRobert J Gil, Jacek Bil, Maik J Grundeken, et al.
Journal of Pediatric Surgery|June 4, 2014
Initial bladder closure of the cloacal exstrophy complex: outcome related risk factors and keys to successBhavik B Shah, Heather Di Carlo, Seth D Goldstein, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 25, 2015
Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trialRobert J Gil, Jacek Bil, Maik J Grundeken, et al.
Journal of Clinical Medicine|June 27, 2024
Ten-Year Outcomes in Patients Undergoing Simultaneous Coronary and Renal Angiography-Does Renal Artery Stenosis Matter?Adam Kern, Tomasz Stompór, Krystian Bojko, et al.
Kardiologia Polska|March 20, 2025
Ten-year outcomes of patients undergoing simultaneous coronary and renal angiography: Insights from the KORONEF Registry based on chronic kidney disease and eGFR stratificationAdam Kern, Tomasz Stompór, Krystian Bojko, et al.
Journal of Clinical Medicine|October 26, 2024
Soluble Urokinase Plasminogen Activator Receptor as a Predictor of All-Cause Death in Patients Undergoing Coronary Angiography at 10-Year Follow-UpAdam Kern, Tomasz Stompór, Krystian Bojko, et al.
Biomedicines|January 8, 2025
Comparative Ten-Year Outcomes in Chronic and Acute Coronary Syndrome Patients Undergoing Invasive Diagnostics-Insights from the KORONEF RegistryAdam Kern, Tomasz Stompór, Krystian Bojko, et al.
Pageof 7